NEW YORK (GenomeWeb) – Pressure BioSciences today said that its full-year 2014 revenues declined 7 percent year over year. 

The company recorded $1.4 million in revenues last year compared to $1.5 million in 2013. Product and service revenues grew 40 percent year over year to $1.4 million from $1.0 million, but grant revenues dropped sharply to $24,594 from $456,610. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.